FDA: Philips CPAP Corrections Weren’t Reported; 222,000 Complaints Were Received
SILVER SPRING, Md. — The Food and Drug Administration on Nov. 12 released a recent inspection report of CPAP maker Philips Respironics Inc.’s manufacturing plant following a recall of 15 million...To view the full article, register now.
Already a subscriber? Click here to view full article